Drug Delivery: Infusion Devices
In 2021, global sales of infusion pumps and associated disposables were estimated at nearly $4.4bn, with volumetric and enteral pumps accounting for two-thirds of the market. Market drivers include technological advancements such as the development of devices with needlestick prevention features and dose error reduction software, the expanding use of infusion pumps in home and alternate healthcare settings, the aging of the population and associated increase of chronic conditions requiring infusion drug delivery, and a significant disposables aftermarket. Market limiters include constrained healthcare spending in some countries due to slowed economic growth and legislative uncertainty in the healthcare marketplace, and, in the short term, a decline back to pre-pandemic levels of demand for infusion pumps following a significant COVID-19-related surge in 2020 and into 2021.
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for infusion-based drug delivery devices including volumetric, syringe, ambulatory, disposable, implantable, and enteral pumps and accessories. Countries covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of World. The forecast range for this report is 2021–26.
Related Medtech Insight articles:
- April 4, 2022 - https://medtech.pharmaintelligence.informa.com/MT145258/Fresenius-Kabi-Acquires-Ivenix-For-$240M-To-Expand-Presence-In-Infusion-Pump-Market
- March 16, 2022 - https://medtech.pharmaintelligence.informa.com/MT145197/Minute-Insight-Fresenius-Kabi-Updates-510k-To-Include-Software-Suite
- March 14, 2022 - https://medtech.pharmaintelligence.informa.com/MT145189/Baxters-Recall-Of-Spectrum-Infusion-Pumps-Given-Class-I-Label-By-FDA
- Subscribe to Medtech Insight to view these articles and more!